Abstract
Bladder cancer is a common malignant disease characterized by frequent recurrences1,2. The stage of disease at diagnosis and the presence of surrounding carcinoma in situ are important in determining the disease course of an affected individual3. Despite considerable effort, no accepted immunohistological or molecular markers have been identified to define clinically relevant subsets of bladder cancer. Here we report the identification of clinically relevant subclasses of bladder carcinoma using expression microarray analysis of 40 well characterized bladder tumors. Hierarchical cluster analysis identified three major stages, Ta, T1 and T2-4, with the Ta tumors further classified into subgroups. We built a 32-gene molecular classifier using a cross-validation approach that was able to classify benign and muscle-invasive tumors with close correlation to pathological staging in an independent test set of 68 tumors. The classifier provided new predictive information on disease progression in Ta tumors compared with conventional staging (P < 0.005). To delineate non-recurring Ta tumors from frequently recurring Ta tumors, we analyzed expression patterns in 31 tumors by applying a supervised learning classification methodology, which classified 75% of the samples correctly (P < 0.006). Furthermore, gene expression profiles characterizing each stage and subtype identified their biological properties, producing new potential targets for therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Pisani, P., Parkin, D.M., Bray, F. & Ferlay, J. Estimates of the worldwide mortality from 25 cancers in 1990. Int. J. Cancer 83, 18–29 (1999).
Wolf, H. et al. Bladder tumors. Treated natural history. Prog. Clin. Biol. Res. 221, 223–255 (1986).
Cheng, L. et al. Survival of patients with carcinoma in situ of the urinary bladder. Cancer 85, 2469–2474 (1999).
Golub, T.R. et al. Molecular classification of cancer: class discovery and class prediction by gene-expression monitoring. Science 286, 531–537 (1999).
Khan, J. et al. Classification and diagnostic prediction of cancers using gene-expression profiling and artificial neural networks. Nat. Med. 7, 673–679 (2001).
Perou, C.M. et al. Molecular portraits of human breast tumors. Nature 406, 747–752 (2000).
Alizadeh, A.A. et al. Distinct types of diffuse large B-cell lymphoma identified by gene-expression profiling. Nature 403, 503–511 (2000).
Ross, D.T. et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat. Genet. 24, 227–235 (2000).
Takahashi, M. et al. Gene-expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc. Natl. Acad. Sci. USA 98, 9754–9759 (2001).
Sorlie, T. et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc. Natl. Acad. Sci. USA 98, 10869–10874 (2001).
Shipp, M.A. et al. Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat. Med. 8, 68–74 (2002).
van't Veer, L.J. et al. Gene-expression profiling predicts clinical outcome of breast cancer. Nature 415, 530–536 (2002).
Alon, U. et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 96, 6745–6750 (1999).
Luo, J. et al. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene-expression profiling. Cancer Res. 61, 4683–4688 (2001).
Notterman, D.A., Alon, U., Sierk, A.J. & Levine, A.J. Transcriptional gene-expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res. 61, 3124–3130 (2001).
Perou, C.M. et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl. Acad. Sci. USA 96, 9212–9217 (1999).
Dhanasekaran, S.M. et al. Delineation of prognostic biomarkers in prostate cancer. Nature 412, 822–826 (2001).
Thykjaer, T. et al. Identification of gene expression patterns in superficial and invasive human bladder cancer. Cancer Res. 61, 2492–2499 (2001).
Seymour, L. Novel anti-cancer agents in development: exciting prospects and new challenges. Cancer Treat. Rev. 25, 301–312 (1999).
Fox, S.B., Gasparini, G. & Harris, A.L. Angiogenesis: pathological, prognostic, and growth-factor pathways and their link to trial design and anticancer drugs. Lancet Oncol. 2, 278–289 (2001).
Ørntoft, T.F. et al. Genome-wide study of gene copy numbers, transcripts, and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas. Mol. Cell. Proteomics 1, 37–45 (2002).
Kerr, J.S., Slee, A.M. & Mousa, S.A. Small molecule alpha(v) integrin antagonists: novel anticancer agents. Expert Opin. Investig. Drugs 9, 1271–1279 (2000).
Bergkvist, A., Ljungqvist, A. & Moberger, G. Classification of bladder tumors based on the cellular pattern. Preliminary report of a clinical–pathological study of 300 cases with a minimum follow-up of eight years. Acta Chir. Scand. 130, 371–378 (1965).
Li, C. & Hung, W.W. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol. 2, RESEARCH0032 (2001).
Eisen, M.B., Spellman, P.T., Brown, P.O. & Botstein, D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. USA 95, 14863–14868 (1998).
Kononen, J. et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat. Med. 4, 844–847 (1998).
Acknowledgements
We thank K.Y. Jonsdottir for computational assistance, H. Steen, B. Pytlick, J.C. Djurhuus, B. Stougaard and B. Devantié for excellent assistance, and the staff at the Departments of Urology, Clinical Biochemistry and Pathology at Aarhus University Hospital. We acknowledge support from the Karen Elise Jensen Foundation, The Danish Cancer Society, EOS Biotechnology, the John and Birthe Meyers Foundation, The Institute of Experimental Clinical Research, The University and County of Aarhus and the Danish Research Council.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
T.F.O., T.T. and M.K. co-founded AROS Applied Biotechnology ApS in the year 2000.
Rights and permissions
About this article
Cite this article
Dyrskjøt, L., Thykjaer, T., Kruhøffer, M. et al. Identifying distinct classes of bladder carcinoma using microarrays. Nat Genet 33, 90–96 (2003). https://doi.org/10.1038/ng1061
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ng1061
This article is cited by
-
Ensemble methods of rank-based trees for single sample classification with gene expression profiles
Journal of Translational Medicine (2024)
-
Bioinformatics in urology — molecular characterization of pathophysiology and response to treatment
Nature Reviews Urology (2024)
-
Activation of CTNNB1 by deubiquitinase UCHL3-mediated stabilization facilitates bladder cancer progression
Journal of Translational Medicine (2023)
-
Device-assisted intravesical chemotherapy versus bacillus Calmette–Guerin for intermediate or high-risk non-muscle invasive bladder cancer: a systematic reviewer and meta-analysis
International Urology and Nephrology (2023)
-
Raman spectroscopy biochemical characterisation of bladder cancer cisplatin resistance regulated by FDFT1: a review
Cellular & Molecular Biology Letters (2022)